Arthritis news. Anytime. Anywhere.

ACE goes to Saskatoon for the 2015 CADTH Symposium

ACE goes to Saskatoon for the 2015 CADTH Symposium

Making arthritis news: Sharing the latest from the Paris of the Prairies 

CADTH 2015 PosterArthritis Consumer Experts (ACE) will be in Saskatoon, the “Paris of the Prairies”, to attend the 2015 CADTH Symposium at TCU Place. The meeting, between Sunday, April 12 and Tuesday, April 14, will bring together producers and users of evidence-based information on drugs and health technologies to learn about, collaborate and share the latest advances in health research and care.  Each year, the symposium attracts an estimated 650 delegates from key sectors, including Health Technology Assessment (HTA) producers, health economists, government, universities, healthcare providers, industry and patient groups.  Continue reading

mensuel JointHealth™ – Guide annuel JointHealth™ sur les médicaments

Guide annuel JointHealth™ sur les médicaments

Le guide de référence rapide et fiable sur les médicaments contre l’arthrite qui sera d’une grande utilité pour vous et votre équipe de soins lorsqu’il s’agira de passer à l’étape « Parlons médicaments »

French March JHM Title PageCette année encore, le Guide des médicaments JointHealth™ vous offre, à vous, à nos membres, à nos abonnés et à nos visiteurs en ligne, de l’information factuelle et concise sur les médicaments les plus fréquemment prescrits dans le traitement des formes inflammatoires de l’arthrite et de l’arthrose. Des articles de fond sur de nouveaux médicaments, les progrès scientifiques permettant de mieux comprendre l’importance de l’initiation en temps opportun de la médication en dose appropriée et le point de vue du patient à l’étape « Parlons médicaments » sont des éléments essentiels qui ouvrent la voie à la « médecine personnalisée ».

Vous trouverez dans cette édition du Guide des médicaments les renseignements sur les médicaments utilisés dans le traitement des maladies suivantes : la polyarthrite rhumatoïde, la spondylarthrite ankylosante, l’arthrite juvénile idiopathique (systémique), l’arthrite psoriasique, le lupus érythémateux disséminé, la vascularite, l’arthrose et l’ostéoporose.

Dans ce numéro du mensuel JointHealth™, vous trouverez également :

  • Des précisions sur un nouveau médicament à petite molécule cible et un nouveau produit biologique ultérieur, approuvés au Canada en 2014.
  • Une entrevue avec Alison Hoens, atteinte de polyarthrite rhumatoïde, sur les choix des médicaments dans un plan de traitement.
  • Un historique de l’utilisation de la méthotrexate dans le traitement de l’arthrite.
  • La recherche émergente dans le domaine de la médecine personnalisée.

JointHealth™ monthly – The JointHealth™ Medications Guide issue

Annual JointHealth™ Medications Guide: A consumer’s guide to arthritis medications

The reliable, quick reference arthritis medications guide you need to assist you and your health care team with your therapy conversations 

Picture of JHM MarchThis year’s JointHealth™ Medications Guide gives you, our member, subscriber and on-line visitor concise, fact-based information on the most commonly prescribed medications for inflammatory types of arthritis and osteoarthritis. Feature articles about new medications and scientific advances that give a deeper understanding of the importance of timely initiation of medication therapy in appropriate doses, and a patient’s perspective on the therapy conversation, are key pieces that lead toward “personalized medicine”.

Medication information for the following diseases is included in this year’s guide: rheumatoid arthritis, spondyloarthritis, (systemic) juvenile idiopathic arthritis, psoriatic arthritis, systemic lupus erythematosus, vasculitis, osteoarthritis, and osteoporosis.

In this JointHealth™ monthly, you will also find:

  • An explanation of a new targeted small molecule medication and a subsequent entry biologic approved in Canada in 2014.
  • An interview with Alison Hoens, a woman living with rheumatoid arthritis, about therapy choices.
  • A history of methotrexate as an arthritis treatment.
  • Emerging research in the field of personalized medicine.

Hat’s off to surgeon and innovator Cy Frank

The recent passing of surgeon and innovator Cy Frank cast a grey shadow over Canada’s health care community. Dr. Frank was the President and CEO of Alberta Innovates Health Solutions (AIHS), which funds research and promotes innovation in the health system. On March 5, he died in his sleep of a heart attack, at the age of 65.

In an interview with the Globe and Mail, Tom Noseworthy, associate chief medical officer for clinical networks and clinical care pathways at Alberta Health Services, said: “Cy was a visionary leader with a constant, unrelenting commitment to the greater good. It was his preoccupation – obsession even – to make the health system better, and he did.”

Dr. Cyril Frank

Picture from the University of Calgary

Continue reading

Let BC PharmaCare hear “Your Voice” on apremilast for plaque psoriasis

Cartoon man with arrowLet BC PharmaCare hear “Your Voice” on apremilast for plaque psoriasis 

BC PharmaCare is looking for your input on apremilast for the treatment of moderate to severe plaque psoriasis 

Taken orally, apremilast (Otezla®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out a questionnaire on a website called Your Voice, you can provide feedback about apremilast for the treatment of moderate to severe plaque psoriasis.

You can give input if you are a B.C. resident and have plaque psoriasis (with or without psoriatic arthritis), a caregiver to someone with plaque psoriasis, or if your group represents people who live with plaque psorisais.  Continue reading

Online survey: Share YOUR thoughts about a new app to help you be more active

ICON ImageOnline survey: Share YOUR thoughts about a new app to help you be more active

Did you know that walking 10 blocks a day can help improve cognitive health and may even be good for joint health in the long term?

Canadian health consumers like you are developing a new app, called Walk 10 Blocks, that will help you and your friends become more physically active in your neighbourhood, and even make it fun! Continue reading